Amendment S-5129 to HF 2573
Creating funds relating to the abatement of and response to opioid use, allowing school districts to obtain opioid antagonist prescriptions, and making an appropriation
Adopted · May 24, 2022
Filed April 14, 2022 in the Senate by
What it changes
- Page 1, by striking lines 1 through 28 and inserting: “Section
- Section 13.2, subsection 1, Code 2022, is amended by adding the following new paragraph: NEW PARAGRAPH . p. Submit a report by January 15 of each year to the co-chairpersons and ranking members of the joint appropriations subcommittee on the justice system detailing any moneys paid to the state as a result of a national settlement of litigation with entities that manufactured, marketed, sold, distributed, dispensed, or promoted opioids. The report shall include the total amount of moneys received each year from the settlement of litigation, the current balance of any funds maintained for the receipt of opioid settlement moneys, and how any moneys received were spent during the prior report period. Sec. ___. Section 135.190, subsection 1, paragraph d, Code 2022, is amended to read as follows: d. “Person in a position to assist” means a family member, friend, caregiver, health care provider, employee of a substance abuse treatment facility, school employee, or other person who may be in a place to render aid to a person at risk of experiencing an opioid-related overdose. Sec. ___. Section 135.190, Code 2022, is amended by adding the following new subsection: NEW SUBSECTION . 4A. A school district may obtain a valid prescription for an opioid antagonist and maintain a supply of opioid antagonists in a secure location at each location where a student may be present for use as provided in this section.”
- Title page, by striking lines 1 and 2 and inserting “An Act requiring an annual report concerning opioid settlement litigation funds, creating an opioid antagonist medication fund, and allowing school districts to obtain opioid antagonist prescriptions.”
- By renumbering as necessary.